Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Skyrizi (risankizumab-rzaa) for Ulcerative Colitis

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved Skyrizi® (risankizumab-rzaa) for adults with moderately...

FDA Approves Vigafyde (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution

(BUSINESS WIRE) June 17, 2024 --Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for...

FDA Approves Capvaxive (pneumococcal 21-valent conjugate vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

(BUSINESS WIRE) June 17, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug...

FDA Approves Yimmugo (immune globulin intravenous, human-dira) to Treat Primary Immunodeficiencies

Barcelona, Spain, June 17, 2024 – Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), one of the world’s leading producers of plasma-derived medicines,...

FDA Approves Merck’s Keytruda (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma

(BUSINESS WIRE) June 17, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration...

High Rates of Loneliness Seen Among Bisexual and Transgender People

Transgender and bisexual adults have rates of loneliness that are much higher than that of cisgender and heterosexual people, new data shows. Federal...

Cognitive Impairment Delayed With Genetic Variant

Cognitive impairment is delayed among persons who are heterozygous for the apolipoprotein E3 Christchurch variant (APOE3Ch), according to a study published...

ViPOR Results in Durable Remission in Specific Subtypes of Lymphoma

For patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with venetoclax, ibrutinib, prednisone,...

About One-Third of Mental Health Facilities Offer Meds for Opioid Addiction

About one-third of community outpatient mental health treatment facilities (MHTFs) offer medications for opioid use disorder (MOUD), according to a study...

Burden of Chronic Health Conditions Increased for LGTBQ+ Cancer Survivors

Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, plus (LGBTQ+) have an increased burden of all chronic health conditions, disabilities,...

Microplastics Found in Human Penises

Seven different kinds of microplastics have been discovered in human penises for the first time. The tiny fragments, formed when plastic products break...

Could Blood Pressure Meds Help Prevent Adult Epilepsy?

A class of blood pressure medications appears to also help lower seniors’ risk of developing epilepsy, a new study finds. The drugs, called angiotensin...

Colombian Family's Genes Could Hold Key to Delaying Alzheimer's

A Colombian family’s genetics are shining a spotlight on a gene that might help protect people from the ravages of Alzheimer’s disease. About...

Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults

SHANGHAI, June 18, 2024. Clover Biopharmaceuticals, Ltd. (Clover), a global commercial-stage biotechnology company committed to unleashing the power...

Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 17, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced topline data from its SKYLINE and SKYWAY studies. SKYLINE...

There May Be 6 Types of Depression, and Brain Scans Can Sort Them Out

Depression can be sorted into six distinct types using brain scans, a revelation that could improve treatment for many suffering the debilitating mood...

Read more news...

Recently Added

Recently added consumer and prescribing information: Yimmugo, Iqirvo, Rytelo, mRESVIA, Bkemv, Yesafili, Myhibbin, Rezenopy, Libervant, Beqvez

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Vigafyde Vigafyde (vigabatrin) is a ready-to-use oral solution formulation of the approved anti-seizure medicine vigabatrin used for the treatment...
  • Capvaxive Capvaxive (pneumococcal 21-valent conjugate vaccine) is a 21-valent pneumococcal conjugate vaccine indicated for active immunization for...
  • Yimmugo Yimmugo (immune globulin intravenous, human-dira) is an immune globulin liquid for intravenous injection indicated for the treatment of...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...

More drugs in development